Nabriva Therapeutics PLC (NASDAQ:NBRV)

2.10
Delayed Data
As of 4:00pm ET
 -0.07 / -3.23%
Today’s Change
2.04
Today|||52-Week Range
21.86
-85.97%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$6.5M

Company Description

Nabriva Therapeutics Plc is a biopharmaceutical company, which engages in the research, development, and commercialization of novel anti-infective agents to treat serious infections. Its product pipeline includes Lefamulin, CONTEPO, and BC-7013. The company was founded in October 2005 and is headquartered in Dublin, Ireland.

Contact Information

Nabriva Therapeutics Plc
25-28 North Wall Quay
Dublin Dublin 1
P:(531) 649-2000
Investor Relations:

Employees

Shareholders

Other institutional1.03%
Individual stakeholders1.01%
Mutual fund holders0.79%

Top Executives

Theodore R. SchroederChief Executive Officer & Director
Steven P. GelonePresident, Chief Operating Officer & Director
Dan DolanChief Financial Officer
Christine Guico-PabiaChief Medical Officer
Jodi VanDerveerSenior Vice President & Head-Human Resources